Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rieser

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Immunology|August 26, 1998
Human monocyte-derived dendritic cells produce macrophage colony-stimulating factor: enhancement of c-fms expression by interleukin-10C Rieser, R Ramoner, G Böck, et al.
American Journal of Ophthalmology|February 1, 1979
Primary radiation therapy for meibomian gland carcinomaR L Hendley, J C Rieser, H D Cavanagh, et al.
Urologia Internationalis|March 30, 2000
Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinomaC Rieser, R Ramoner, L Höltl, et al.
Blood|May 23, 1998
Differential deactivation of human dendritic cells by endotoxin desensitization: role of tumor necrosis factor-alpha and prostaglandin E2C Rieser, C Papesh, M Herold, et al.
The Journal of Urology|February 18, 1999
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cellsL Höltl, C Rieser, C Papesh, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 29, 2000
Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertensionW C Stewart, E D Sharpe, D G Day, et al.
British Journal of Cancer|October 29, 1998
Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cellsZ Culig, A Hobisch, M Herold, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Immunology|August 26, 1998
Human monocyte-derived dendritic cells produce macrophage colony-stimulating factor: enhancement of c-fms expression by interleukin-10C Rieser, R Ramoner, G Böck, et al.
American Journal of Ophthalmology|February 1, 1979
Primary radiation therapy for meibomian gland carcinomaR L Hendley, J C Rieser, H D Cavanagh, et al.
Urologia Internationalis|March 30, 2000
Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinomaC Rieser, R Ramoner, L Höltl, et al.
Blood|May 23, 1998
Differential deactivation of human dendritic cells by endotoxin desensitization: role of tumor necrosis factor-alpha and prostaglandin E2C Rieser, C Papesh, M Herold, et al.
The Journal of Urology|February 18, 1999
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cellsL Höltl, C Rieser, C Papesh, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 29, 2000
Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertensionW C Stewart, E D Sharpe, D G Day, et al.
British Journal of Cancer|October 29, 1998
Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cellsZ Culig, A Hobisch, M Herold, et al.
Pageof 2